391 related articles for article (PubMed ID: 33547233)
21. DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.
Kawai M; Nakamura T; Miura N; Maeta M; Tanaka H; Ueda K; Higashi K; Moribe K; Tange K; Nakai Y; Yoshioka H; Harashima H; Akita H
Nanomedicine; 2018 Nov; 14(8):2587-2597. PubMed ID: 30170077
[TBL] [Abstract][Full Text] [Related]
22. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
23. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
24. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.
Xu Y; Ma S; Zhao J; Chen H; Si X; Huang Z; Yu Z; Song W; Tang Z; Chen X
Biomaterials; 2022 May; 284():121489. PubMed ID: 35364489
[TBL] [Abstract][Full Text] [Related]
25. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells.
Verbeke R; Lentacker I; Breckpot K; Janssens J; Van Calenbergh S; De Smedt SC; Dewitte H
ACS Nano; 2019 Feb; 13(2):1655-1669. PubMed ID: 30742405
[TBL] [Abstract][Full Text] [Related]
26. Curdlan activates dendritic cells through dectin-1 and toll-like receptor 4 signaling.
Kim HS; Park KH; Lee HK; Kim JS; Kim YG; Lee JH; Kim KH; Yun J; Hwang BY; Hong JT; Kim Y; Han SB
Int Immunopharmacol; 2016 Oct; 39():71-78. PubMed ID: 27449326
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responses.
Davis MB; Vasquez-Dunddel D; Fu J; Albesiano E; Pardoll D; Kim YJ
Clin Cancer Res; 2011 Jun; 17(12):3984-92. PubMed ID: 21543518
[TBL] [Abstract][Full Text] [Related]
28. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
29. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity.
Zhu Y; Ma J; Shen R; Lin J; Li S; Lu X; Stelzel JL; Kong J; Cheng L; Vuong I; Yao ZC; Wei C; Korinetz NM; Toh WH; Choy J; Reynolds RA; Shears MJ; Cho WJ; Livingston NK; Howard GP; Hu Y; Tzeng SY; Zack DJ; Green JJ; Zheng L; Doloff JC; Schneck JP; Reddy SK; Murphy SC; Mao HQ
Nat Biomed Eng; 2024 May; 8(5):544-560. PubMed ID: 38082180
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.
Van Lint S; Renmans D; Broos K; Goethals L; Maenhout S; Benteyn D; Goyvaerts C; Du Four S; Van der Jeught K; Bialkowski L; Flamand V; Heirman C; Thielemans K; Breckpot K
Cancer Immunol Res; 2016 Feb; 4(2):146-56. PubMed ID: 26659303
[TBL] [Abstract][Full Text] [Related]
31. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.
Oyama R; Ishigame H; Tanaka H; Tateshita N; Itazawa M; Imai R; Nishiumi N; Kishikawa JI; Kato T; Anindita J; Nishikawa Y; Maeki M; Tokeshi M; Tange K; Nakai Y; Sakurai Y; Okada T; Akita H
ACS Nano; 2023 Oct; 17(19):18758-18774. PubMed ID: 37814788
[TBL] [Abstract][Full Text] [Related]
32. Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling.
Lugade AA; Bianchi-Smiraglia A; Pradhan V; Elkin G; Murphy TF; Thanavala Y
PLoS One; 2011; 6(5):e19781. PubMed ID: 21611194
[TBL] [Abstract][Full Text] [Related]
33. "Minimalist" Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy.
Wang K; Wen S; He L; Li A; Li Y; Dong H; Li W; Ren T; Shi D; Li Y
ACS Nano; 2018 Jul; 12(7):6398-6409. PubMed ID: 29927574
[TBL] [Abstract][Full Text] [Related]
34. Maturation of murine bone marrow-derived dendritic cells induced by Radix Glycyrrhizae polysaccharide.
Li X; He X; Liu B; Xu L; Lu C; Zhao H; Niu X; Chen S; Lu A
Molecules; 2012 May; 17(6):6557-68. PubMed ID: 22728353
[TBL] [Abstract][Full Text] [Related]
35. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Kranz LM; Diken M; Haas H; Kreiter S; Loquai C; Reuter KC; Meng M; Fritz D; Vascotto F; Hefesha H; Grunwitz C; Vormehr M; Hüsemann Y; Selmi A; Kuhn AN; Buck J; Derhovanessian E; Rae R; Attig S; Diekmann J; Jabulowsky RA; Heesch S; Hassel J; Langguth P; Grabbe S; Huber C; Türeci Ö; Sahin U
Nature; 2016 Jun; 534(7607):396-401. PubMed ID: 27281205
[TBL] [Abstract][Full Text] [Related]
36. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
37. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells.
Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V
J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987
[TBL] [Abstract][Full Text] [Related]
39. Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles.
Daneshmandi S; Pourfathollah AA; Forouzandeh-Moghaddam M
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):375-386. PubMed ID: 30265161
[No Abstract] [Full Text] [Related]
40. Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety.
Van der Jeught K; De Koker S; Bialkowski L; Heirman C; Tjok Joe P; Perche F; Maenhout S; Bevers S; Broos K; Deswarte K; Malard V; Hammad H; Baril P; Benvegnu T; Jaffrès PA; Kooijmans SAA; Schiffelers R; Lienenklaus S; Midoux P; Pichon C; Breckpot K; Thielemans K
ACS Nano; 2018 Oct; 12(10):9815-9829. PubMed ID: 30256609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
